3-Bromopyruvate is known for glycolytic inhibitors. Potential target is hexoknase II and/or glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
|Catalog #||Material Name||Company Name||Solute/Solvent|
In vitro test:
Dissolve in distilled water to make a 0.5 M stock solution. Aliquote and store at -20 degree
1. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells. Science. 2009; 325:1555. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Wilson JK, Markowitz S, Zhou S, Diaz LA Jr, Velculescu V, Lengauer C, Kinzler KW, Vogelstein B, Papadopoulos N.
|Antibodies from Epitomics|
|Over 6800 high quality antibodies from Epitomics. All Epitomics antibodies are validated in WB, IHC, ICC/IF, IP and FACS. Learn more|
|MyGenostics, Your Exome|
|GenCapTM technology captures both strands of the Exome with superior evenness for reduced sequencing costs.|
|High Throughput Applications|
|Silica membrane kits in flexible 8-well and 96-well formats, ultrafiltration and magnetic beads for all applications. Contact a specialist|